50 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Scopus BioPharma Inc. SCPS shares jumped 500% to $35.52. Scopus BioPharma’s filing showed registration for 500,000 share common stock offering. Scopus Biopharma shares gained around 8% on Wednesday after the company priced its IPO at $5.5 per share.
• MingZhu Logistics Holdings Ltd YGMZ shares climbed 205% to $12.22 .
• Nxt-ID, Inc. NXTD climbed 94.3% to $1.7950 after jumping around 90% on Wednesday.
• Oriental Culture Holding Ltd OCG gained 90.8% to $11.64 as a potential post IPO volatility. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.
• Wunong Net Technology Company Limited WNW shares gained 80.1% to $117.22 after jumping 440% on Wednesday. The company, on Tuesday, priced its IPO at $5 per share.
• Vivos Therapeutics, Inc. VVOS climbed 37.4% to $9.31. Vivos Therapeutics, earlier during the month, priced its IPO at $6 a share.
• Jupiter Wellness, Inc. JUPW gained 36.1% to $7.20 after climbing 19% on Wednesday. Jupiter Wellness, recently reported the acquisition of SRM Entertainment, LTD from Vinco Ventures, Inc.
• Avenue Therapeutics, Inc. ATXI rose 30% to $4.79 after the company issued regulatory update for IV Tramadol.
• Lixte Biotechnology Holdings, Inc. LIXT surged 30% to $4.2916.
• Upstart Holdings, Inc. UPST gained 24% to $36.53. Upstart Holdings shares surged 47% on Wednesday after the company priced its IPO at $20 per share.
• Evolus, Inc. EOLS rose 22.6% to $4.50 after the company issued an update on United States International Trade Commission (ITC) case.
• Marathon Patent Group, Inc.. MARA gained 22.6% to $10.09 after surging 16% on Wednesday.
• PainReform Ltd. PRFX jumped 20% to $5.20.
• Rite Aid Corporation RAD climbed 18% to $20.18 after the company reported better-than-expected Q3 results and issued strong FY21 guidance .
• Bit Digital, Inc. BTBT shares climbed 17.8% to $5.95 following an 18% decline on Wednesday. Bit Digital, earlier during the month, highlighted completion of acquisition of $13,902,742 worth of bitcoin miners with total hash rate of 1,003.5 Ph/s.
• TuanChe Limited TC surged 17.8% to $5.03.
• MiMedx Group, Inc. MDXG surged 16.4% to $9.11. MiMedx Group shares jumped 19% on Wednesday after Prescience Point Capital Management, a company shareholder, gave bullish commentary on the stock and issued a $31 price target.
• Cogent Biosciences, Inc. COGT gained 16.3% to $12.65. SVB Leerink, on Wednesday, initiated coverage on Cogent Biosciences with an Outperform rating and a price target of $20.
• Canaan Inc. CAN rose 16.1% to $4.41 after gaining around 7% on Wednesday.
• fuboTV Inc. FUBO gained 15.8% to $34.41.
• Drive Shack Inc. DS surged 14.8% to $3.25. Drive Shack is scheduled to reopen its Orlando venue on December 18th.
• Skillful Craftsman Education Technology Limited EDTK rose 14.7% to $3.3211.
• Ondas Holdings Inc. ONDS shares jumped 14.5% to $7.10.
• Enlivex Therapeutics Ltd. ENLV rose 10.4% to $11.30. Enlivex, earlier during the month, reported issuance of new Chinese patent covering allocetra immunotherapy.
• 9 Meters Biopharma, Inc. NMTR rose 8.6% to $0.82. OrbiMed Israel BioFund GP Limited Partnership reported a 16% stake in 9 Meters Biopharma.
• Accenture plc ACN rose 8.5% to $268.55 after the company reported upbeat Q1 results and issued strong Q2 sales forecast.
• Jabil Inc JBL climbed 6.6% to $43.75 after the company posted upbeat Q1 results and issued strong Q2 earnings outlook.
• Lennar Corporation LEN rose 6% to $78.77 following upbeat quarterly earnings.
• Roku, Inc. ROKU rose 4.3% to $339.79. Roku is partnering with AT&T’s subscription video-on-demand streaming service HBO Max starting Thursday.

Check out these big penny stock gainers and losers

Losers

• Triterras Inc TRIT shares dipped 36.5% to $8.39 after confirming it informed a statutory demand for payment was made to Antanium Resources in Singapore. Triterras said in a regulatory filing it was informed that a statutory demand for payment from Antainium Resources (formerly known as Rhodium Resources) was filed by a creditor of Rhodium on Dec. 1.
• BioCardia Inc BCDA fell 25.5% to $4.3189. BioCardia disclosed positive DSMB review and recommendation to continue Phase III pivotal CardiAMP heart failure study as designed. BioCardia recently reported a 1.789 million share registered direct offering priced at $4.75 per share.
• CooTek (Cayman) Inc. CTK shares dipped 22.5% to $3.1473. CooTek, on Wednesday, reported a mixed securities shelf offering.
• Dragon Victory International Limited LYL dropped 19.5% to $2.2292.
• Mediaco Holding Inc MDIA fell 19.2% to $2.91 after climbing around 35% on Wednesday.
• SCYNEXIS, Inc. SCYX fell 18.3% to $5.99 after the company announced the launch of $50 million common stock and warrant offering.
• Uxin Limited UXIN fell 17.3% to $1.1582 after reporting Q2 results.
• Standard Motor Products, Inc. SMP shares dropped 15.8% to $45.39.
• Zynerba Pharmaceuticals, Inc. ZYNE dipped 15.7% to $3.52 as the company issued regulatory update on Zygel in Fragile X syndrome.
• Hancock Jaffe Laboratories, Inc. HJLI dropped 14% to $8.90. FatBoy Capital, on Wednesday, disclosed a 6.9% active stake in the company.
• Surface Oncology, Inc. SURF fell 13.7% to $8.60. Surface Oncology announced an agreement for GlaxoSmithKline to exclusively license worldwide development and commercial rights to its preclinical program SRF813, an inhibitory protein expressed on natural killer cells and T cells, for an $85-million upfront payment.
• Herman Miller, Inc. MLHR dropped 13.2% to $35.20 after reporting Q2 results.
• R. R. Donnelley & Sons Company RRD fell 12.8% to $1.8220 after climbing around 19% on Wednesday. R.R. Donnelley, last week, reported a vaccination distribution toolkit to support marketing and operations for pending COVID-19 vaccine.
• Phathom Pharmaceuticals, Inc. PHAT dropped 12.6% to $40.25 as the company reported pricing of public offering of common stock.
• Atossa Therapeutics, Inc. ATOS shares fell 9.8% to $0.8659 after gaining around 10% on Wednesday. Atossa Therapeutics, last week, priced a $20 million underwritten public offering.
• Qutoutiao Inc. QTT fell 9.7% to $2.2582 following Q3 results.
• CureVac N.V. CVAC fell 9% to $105.75. CureVac recently announced the commencement of its global pivotal Phase2b/3 trial for its Covid-19 vaccine candidate CVnCoV.
• Apollo Endosurgery, Inc. APEN shares fell 7.8% to $3.66. Apollo Endosurgery, on Wednesday, announced it received FDA clearance for the X-Tack Endoscopic HeliX Tacking System.
• Heat Biologics, Inc. HTBX fell 6.6% to $5.51. Heat Biologics shares climbed around 10% on Wednesday after the company announced completion of ZVX-60 vaccine cell line for COVID-19.
• Allied Esports Entertainment Inc. AESE fell 5.3% to $1.5150. Allied Esports, on Wednesday, launches 24-hour cross-channel content strategy on Twitch.
• Aethlon Medical, Inc. AEMD fell 5.1% to $2.1450. Aethlon Medical shares jumped over 40% on Wednesday after the company treated the first patient in its first-in-human Early Feasibility Study of the HEMOPURIFIER.